Galt therapeutics
WebApr 13, 2024 · Galectin Therapeutics Price Performance. Galectin Therapeutics stock opened at $2.04 on Thursday. The stock has a market capitalization of $121.26 million, a PE ratio of -3.14 and a beta of 1.45. WebFind real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.
Galt therapeutics
Did you know?
WebApr 13, 2024 · Galectin Therapeutics Price Performance. Shares of GALT opened at $2.04 on Thursday. Galectin Therapeutics has a one year low of $1.02 and a one year high of $2.57. The company has a market cap of ... Web18 hours ago · Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update 03/30/23-8:00AM EST GlobeNewswire Galectin Therapeutics GAAP EPS of -$0.65 in-line
WebMar 21, 2007 · Galectin Therapeutics Inc. (GALT) Message Board - Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: Biotechs - Total Posts: 3791 - Last Post: 03/14/2024 01:04:40 AM - company/specific stock board WebApr 10, 2024 · GALT Complete Galectin Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Web1 hour ago · As mentioned above, biotechnology companies like Galectin Therapeutics, Bioxytran and Galecto are dominating the development of drugs against galectins. A majority of drugs are being created to ... WebMar 30, 2024 · About Galectin Therapeutics. Galectin Therapeutics is dedicated to developing novel therapies to improve the lives of patients with chronic liver disease and cancer. Galectin’s lead drug belapectin (formerly known as GR-MD-02) is a carbohydrate-based drug that inhibits the galectin-3 protein, which is directly involved in multiple ...
WebJun 6, 2024 · NORCROSS, Ga., June 06, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company ...
Web2 days ago · Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to … furhaven coverWebGalectin Therapeutics Inc Stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for GALT in the last 3 months. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. github r2apiWebGalectin Therapeutics is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. github r3WebJan 5, 2024 · NORCROSS, Ga., Oct. 05, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will be participating in the H.C. Wainwright 5th Annual NASH Investor Conference being held virtually on October 12, 2024. github r10WebApr 10, 2024 · Galectin Therapeutics to Present in Upcoming H.C. Wainwright Global Investment Conference and the 5th Global NASH Congress. NORCROSS, Ga., May 23, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company … github r2d2WebGalectin Therapeutics Inc. Common Stock (GALT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. github r0tracerWebGalectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. furhaven corry pa address